Herantis Pharma to Participate in the Upcoming Investor Conferences

On November 3, 2021 Herantis Pharma Plc ("Herantis"), focusing on disease modifying therapies for debilitating neurodegenerative diseases, reported that Dr. Craig Cook, Chief Executive Officer, will hold 1×1 meetings and have a company presentation at the following investor conferences (Press release, Herantis Pharma, NOV 3, 2021, View Source,c3446216 [SID1234594328]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Redeye Life Science Day 2021 – November 11th (Virtual)

Virtual Presentation at 16:10 – 16:30 EET / 15:10 – 15:30 CET

H.C. Wainwright 7th Annual Israel Virtual Conference – November 15, 2021

1×1 meetings and virtual presentation.

8th China HealthCare Summit, November 18 – 19, 2021 (Virtual)

1×1 meetings and virtual presentation.

All presentations will be available via a digital library, which is accessible to event participants only. Please contact the conference organizers, or send an email to [email protected], if you wish to schedule a meeting with Herantis.